Influenza Medication Market Size | COVID-19 Impact Analysis | Forecast to 2027

The global influenza medication market is expected to grow at a significant CAGR during the forecast period (2021-2027).  Over the last few decades, the number of severe and life-threatening infectious diseases has increased across the globe. There are various kinds of influenza, which have exhibited a steady increase in occurrence globally. In October 2019, there were 9.7 million influenza cases in the US, according to the Centers for Disease Control and Prevention (CDC). This, in turn, is driving the growth of the market. 

The major companies operating in the industry are highly inclined towards the adoption of different growth strategies including partnerships and collaborations, mergers and acquisitions, geographical expansion, and new product launches to remain competitive in the marketplace. For instance, in October 2019, Xofluza (Baloxavir Marboxil) was approved by the FDA for people who are at a high risk of suffering from influenza-related complications. Shionogi & Co., Ltd. stated in October 2019 that a supplemental New Drug Application (sNDA) for Xofluza (baloxavir marboxil) for the postexposure prophylaxis of influenza virus infection had been filed in Japan. Further, Shionogi & Co., Ltd. announced in August 2019 that Xofluza (Baloxavir Marboxil) 20mg tablets have been approved in Taiwan for the treatment of influenza types A and B in individuals over the age of 12. Xofluza is a first-in-class, single-dose oral drug with a new mechanism of action that inhibits polymerase acidic endonuclease, a viral replication enzyme. 

To Request a Sample of our Report on Influenza Medication Market:   https://www.omrglobal.com/request-sample/influenza-medication-market

In November, 2020, Shionogi & Co., Ltd. announced that F. Hoffmann-La Roche Ltd., which holds global rights to Xofluza except in Japan and Taiwan, has received FDA approval for a supplemental New Drug Application (sNDA) for Xofluza (baloxavir marboxil) as a treatment to prevent influenza in people 12 years of age and older following contact with someone who has influenza (known as post-exposure prophylaxis). In November 2020, Roche announced that the FDA has granted a supplemental New Drug Application (sNDA) for Xofluza (baloxavir marboxil) as a therapy to prevent influenza in patients aged 12 and up who have been exposed to influenza (known as post-exposure prophylaxis).

Market Coverage

•                 The market number available for – 2020-2027

•                 Base year- 2020

•                 Forecast period- 2021-2027

Segment Covered- 

·                  By Product 

·                  By Distribution Channel  

Regions covered-

·                  North America

·                  Europe

·                  Asia-Pacific

·                  Rest of the World

Competitive Landscape:  CSL Ltd., F. Hoffmann-La Roche Ltd., and GlaxoSmithKline plc, among others. 

(Get 15% Discount on Buying this Report)

A full Report of Influenza Medication Market is Available @ https://www.omrglobal.com/industry-reports/influenza-medication-market

Global Influenza Medication Market Report by Segment

By Product 

•             Baloxavir (Marboxil)

•             Zanamivir

•             Oseltamivir

•             Peramivir

•             Amantadine

•             Other (Rimantadine)

By Distribution Channel 

•             Hospitals

•             Clinics

•             Pharmacies

•             Others

Global Influenza Medication Market Report by Region

North America

·        United States

·        Canada

Europe

·        UK

·        Germany

·        Spain

·        France

·        Italy

·        Rest of Europe

Asia-Pacific

·                  India

·                  China

·                  Japan

·                  South Korea

·                  Rest of APAC

Rest of the World

·        Latin America 

·        Middle East & Africa

Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

Comments

Post a Comment

Popular posts from this blog

European Data Backup and Recovery Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

  European Data Backup and Recovery Market are expected to reach $5.7 billion in 2027, growing at a CAGR of 9.5% during the forecast period (2021-2027). Factors responsible for the growth of the market in Europe are well-developed telecommunication infrastructure, high internet penetration, high adoption of cloud-based devices among people and organization. Regulations regarding the data localization such as GDPR by the European Union and countries own data localization and protection act are providing growth to the market. Major economies which are expected to hold a considerable market are UK, Germany, France, Italy, and Spain. These economies are part of the European Union, which covers most of the continent. The aim of the European Union was to increase economic cooperation and encourage free trade among countries. To Request a Sample of our Report on European Data Backup and Recovery Market :   https://www.omrglobal.com/request-sample/european-data-backup-recovery-...
Read more

Insect Repellent Market Is Likely to Experience a Tremendous Growth by 2031

This informative Insect Repellent Market report provides new method and covers foremost regions such as Latin America, Middle East, North America, Europe, Africa and Asia Pacific. Making most out of the consumer insights and market opportunities, market players can boost up the revenue rate of their business. It also permits key organizations to make communication with customers and know their demands for making right investment in the product development. By increasing the product portfolio by referring the important market data provided in this Insect Repellent Market research report, key players can grow and expand their business forward. Continuously developing customer demands are also described in this global report to help new entrants make required changes in the final product launch and then bring into the market. It becomes easy for key players to prioritize the demands and requirements of target audience and have complete understanding of end-user experience with the help o...
Read more

Asia-Pacific Urban Air Mobility Market Growth, Size, Share, Industry Report and Forecast 2019-2025

The Asia-Pacific urban air mobility market is estimated to grow at a CAGR of 12.6% during the forecast period. The Asia-Pacific urban air mobility market is segmented on the basis of component and operation. Based on the component, the market is further segmented into infrastructure and platform. The infrastructure segment is further segmented into charging stations, traffic management, and others whereas, the platform segment is further classified into air taxi, personal air vehicle, air ambulance, and others. The platform segment dominated the global urban air mobility market. To Request a Sample of our Report on Asia-Pacific Urban Air Mobility Market :   https://www.omrglobal.com/request-sample/asia-pacific-urban-air-mobility-market Asia-Pacific is home to several emerging economies and is seen as the potential market for the UAM owing to growing urbanization coupled with increasing traffic congestion and increasing high-income groups in the region. The growth of the As...
Read more